NCT00089310View on ClinicalTrials.gov

Sentinel Lymph Node Mapping in Detecting Cancer That Has Spread to Lymph Nodes in Patients With Non-Small Cell Lung Cancer

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

February 28, 2007

Study Completion Date

April 30, 2009

Conditions
Lung Cancer
Interventions
RADIATION

technetium-99

0.25 mCi in 4 equal doses

Trial Locations (12)

10029

Mount Sinai Medical Center, New York

11373

Elmhurst Hospital Center, Elmhurst

11432

Queens Cancer Center of Queens Hospital, Jamaica

13210

SUNY Upstate Medical University Hospital, Syracuse

19713

CCOP - Christiana Care Health Services, Newark

19958

Beebe Medical Center, Lewes

28805

Veterans Affairs Medical Center - Asheville, Asheville

65201

Veterans Affairs Medical Center - Columbia (Truman Memorial), Columbia

60201-1781

Evanston Northwestern Healthcare - Evanston Hospital, Evanston

08043

Cancer Institute of New Jersey at Cooper - Voorhees, Voorhees Township

14263-0001

Roswell Park Cancer Institute, Buffalo

43210-1240

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University, Columbus

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00089310 - Sentinel Lymph Node Mapping in Detecting Cancer That Has Spread to Lymph Nodes in Patients With Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter